Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 2/20 | 0.41 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2619140 | 0.93 | CYP3A4 (0.55) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL3290903 | 0.85 | CYP3A4 (0.47) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL18120624 | 0.84 | CYP3A4 (0.47) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL5551907 | 0.78 | CYP3A4 (0.74) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL14080769 | 0.74 | CYP3A4 (0.51) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL14081013 | 0.71 | CYP3A4 (0.48) | CYP3A4LMNAUSP2ABCB1 | |
| SCHEMBL14050104 | 0.67 | MEN1 (0.33) | LMNA | |
| SCHEMBL13120128 | 0.67 | MEN1 (0.33) | LMNA | |
| SCHEMBL13105399 | 0.67 | MEN1 (0.33) | LMNA | |
| SCHEMBL13105444 | 0.67 | MEN1 (0.33) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130266556-A9 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2013-10-10 | — | — | US | disclosed |
| US-20130164818-A9 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2013-06-27 | — | — | US | disclosed |
| US-20120094358-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2012-04-19 | — | — | US | disclosed |
| US-20110081336-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2011-04-07 | — | — | US | disclosed |
| US-20100124583-A1 | PROCESSING BIOMASS | XYLECO, INC. (US) | 2010-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110081336-A1 | PROCESSING BIOMASS | FIP1L1, MANBA, BCAT2 | CYP3A4 1414/4885LMNA 2646/4885USP2 1477/4885 |
| US-20130266556-A9 | PROCESSING BIOMASS | FIP1L1, MANBA, BCAT2 | CYP3A4 1414/4885LMNA 2646/4885USP2 1477/4885 |
| US-20100124583-A1 | PROCESSING BIOMASS | FIP1L1, MANBA, BCAT2 | CYP3A4 1414/4885LMNA 2646/4885USP2 1477/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.